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Hepatitis A virus (HAV) is an ancient and ubiquitous human path-
ogen recovered previously only from primates. The sole species of
the genus Hepatovirus, existing in both enveloped and nonenvel-
oped forms, and with a capsid structure intermediate between that
of insect viruses andmammalian picornaviruses, HAV is enigmatic in
its origins. We conducted a targeted search for hepatoviruses in
15,987 specimens collected from 209 small mammal species globally
and discovered highly diversified viruses in bats, rodents, hedge-
hogs, and shrews, which by pairwise sequence distance comprise
13 novel Hepatovirus species. Near-complete genomes from nine of
these species show conservation of unique hepatovirus features,
including predicted internal ribosome entry site structure, a trun-
cated VP4 capsid protein lacking N-terminal myristoylation, a car-
boxyl-terminal pX extension of VP1, VP2 late domains involved in
membrane envelopment, and a cis-acting replication element within
the 3Dpol sequence. Antibodies in some bat sera immunoprecipi-
tated and neutralized human HAV, suggesting conservation of crit-
ical antigenic determinants. Limited phylogenetic cosegregation
among hepatoviruses and their hosts and recombination patterns
are indicative of major hepatovirus host shifts in the past. Ancestral
state reconstructions suggest a Hepatovirus origin in small insectiv-
orous mammals and a rodent origin of human HAV. Patterns of
infection in small mammals mimicked those of human HAV in hep-
atotropism, fecal shedding, acute nature, and extinction of the virus
in a closed host population. The evolutionary conservation of hep-
atovirus structure and pathogenesis provide novel insight into the
origins of HAV and highlight the utility of analyzing animal reser-
voirs for risk assessment of emerging viruses.
hepatitis A virus | viral evolution | pathogenesis | zoonosis | small mammals
Small mammals such as bats and rodents have been implicatedfrequently in the evolution and spread of emerging viruses
(1). It is uncertain whether this reflects unique aspects of their
physiology, immune response to infectious agents, or ecological
traits facilitating virus maintenance such as rapid population turn-
over or tendencies to form large and gregarious social groups (2, 3).
The emergence of Ebola virus from bats (4) and hantaviruses from
rodents (5) exemplifies the prominent contributions of these taxa to
emerging zoonotic threats to human health, but the extent to which
such species have contributed to the evolution of well-established
human pathogens such as hepatitis A virus (HAV) is less clear.
HAV is unique among the Picornaviridae, a large and diverse
family of positive-strand RNA viruses (6), not only in its tropism
for the liver but also in its structure and life cycle. It infects via the
fecal–oral route and is shed in feces as a naked, nonenveloped
particle, but circulates in the blood cloaked in an envelope derived
from host cell membranes (7). Recent X-ray studies have revealed
that HAV possesses a primitive capsid structure related to that of
picorna-like viruses infecting insects, hinting at both an ancient
evolutionary relationship and a novel mechanism of cell entry (8).
The origins of HAV, however, remain shrouded in mystery. De-
spite evidence of limited replication in guinea pigs (9), only higher
primates have been shown to be fully permissive for infection.
HAV strains show little variation in nucleotide sequence over time
or geography, forming six closely related genotypes comprising
only a single serotype (10). Unlike other human hepatitis viruses,
HAV infections never persist and uniformly engender lifelong,
likely antibody-mediated immunity against reinfection (11).
HAV has thus disappeared previously from small, isolated human
populations (12, 13), raising questions as to how it could have
evolved in early human hunter–gatherer societies.
Results
Identification of Nonprimate Hepatoviruses. To elucidate the evolu-
tionary origins of HAV, we sought the presence of HAV-related
viruses in 15,987 specimens (tissue, blood, and feces) collected
globally from 209 species of small mammals in five different mam-
malian orders: Rodentia (rodents), Scandentia (treeshrews), Chi-
roptera (bats), Eulipotyphla (hedgehogs, shrews), and Afrosoricida
(tenrecs; Fig. 1A, Fig. S1A, and Table S1). Hepatoviruses were
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identified by a broadly reactive nested RT-PCR assay targeting the
VP2 domain that is among the most highly conserved segments of
the polyprotein-coding RNA. A total of 117 specimens (0.7%)
were positive, originating from five continents and a total of 28
different nonprimate hosts, including 13 bat species, 13 rodent
species, 1 shrew, and 1 hedgehog species (GenBank accession nos.
KT452631–KT452747). Bayesian phylogenetic reconstruction
demonstrated considerably more diversity among these novel
viruses than primate HAVs, with seven deeply branching clades
forming an extended Hepatovirus tree (Fig. 1B and Fig. S1B).
Phylogenetically basal clades contained shrew and bat viruses from
Central Europe (clade I), African rodent viruses (clade II),
Malagasy and European bat viruses (clade III), American, European,
and African bat viruses (clade IV), and African and European bat
and hedgehog viruses (clade V). Rodent viruses from North America
(clade VI), Asia, and Central Europe (clade VII) clustered phylo-
genetically in an immediate sister relationship to primate hepatoviruses
that form an apical monophyletic group. Pairwise sequence distances
indicate these novel viruses represent 13 new Hepatovirus
species (Fig. S1C).
Only limited phylogenetic cosegregation was evident for these
novel nonprimate hepatoviruses and their mammalian host spe-
cies. When categorized according to host order (Fig. 1C, nodes
a–c), viruses from cricetid rodents in Central Europe and Asia
(node a1), Northern America (node a2), and murid rodents
from Africa (node a3) were not monophyletic. Similarly, viruses
from different bat hosts sampled globally occupied three different
phylogenetic positions (nodes b1–b3), whereas viruses from
Eulipotyphla (hedgehogs and shrews) occupied two different
phylogenetic positions (nodes c1–c2). Even at the level of host
superorder, viruses from Laurasiatheria (bats, hedgehogs, and
shrews), and Euarchontoglires (rodents) were intermixed. In two
instances, however, pairs of genetically closely related viruses were
identified in the same bat genus in biogeographically distinct re-
gions. One virus pair was obtained from Rhinolophus bats from
Southern Europe and Africa and a second pair from Miniopterus
bats in Eastern Europe and Madagascar (Fig. 1C). These two virus
pairs may suggest some limited degree of ancient host–virus
relationships. Finally, closely related viruses were detected in
co-occurring rodent hosts belonging to three highly divergent
families in Central European and Northern American sampling
sites (Fig. 1C). Taken together, the phylogenetic relationships
evident among nonprimate hepatoviruses strongly suggest
multiple host shifts in the past and spillover infections in co-
occurring species.
Consistent with the long branches in the hepatovirus phyloge-
netic tree segregating small mammal viruses, the patristic distance
of hepatoviruses was about fourfold greater in small mammals than
in primates (Fig. 1D). Parsimony-based ancestral state reconstruc-
tions (ASRs) (3) consistently projected the primate HAV ancestor
to a rodent host (Fig. 1E). In contrast, the origin of all mammalian
hepatoviruses was consistently projected to a Laurasiatherian host
and an insectivorous diet. Bats were most relevant hepatovirus
donors for projected host switches, followed by rodents and the
Eulipotyphla (Fig. 1F). No host switch was projected to involve a
primate donor. These results collectively suggest a long and com-
plex evolutionary history of hepatoviruses in small mammals.
Nonprimate Hepatovirus Genome Structure. We determined 14 near-
complete genome sequences of nonprimate hepatoviruses repre-
senting 9 predicted species (Fig. 1C). Each is similar in organization
Fig. 1. Hepatovirus evolutionary relationships. (A) Number of sampled host
genera, specimens, and dates of collection. Country abbreviations, see Table
S1. (B) Hepatovirus VP2 phylogeny (MrBayes, GTR+G+I nucleotide substitution
model). (C) Cladogram of hepatovirus hosts (Left) and Hepatovirus phylogeny
(Right) as in B. Circled numbers, predicted viral species. Diamonds, viral full
genome characterizations. Circles at nodes, posterior probabilities >0.9.
(D) Hepatovirus patristic distance per host order; aa, amino acid. (E) Parsimony-
based ancestral state reconstructions (ASR) as described previously (3) using
10,000 tree replicates of a VP2 phylogeny (MrBayes, WAG aa substitution
model) according to host order (Left) or predominantly insectivorous diet
(Right). (F) Averaged number of host switches from ASR shown in E origi-
nating from and received by each hepatovirus host order.
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and length to human HAV, sharing a characteristically low G/C
content, avoidance of CpG dinucleotides and a strong codon usage
bias (Fig. 2 A and B and Fig. S1D and E) (14). Conserved structural
elements in the 5′UTR of most of these viruses include several
pyrimidine-rich tracts and a large, predicted cruciform stem-loop
resembling the type III HAV internal ribosome entry site (IRES)
(Fig. 2C and Fig. S2A) (15). However, the 5′UTRs of viruses from a
Malagasy bat and a West African rodent are predicted to contain
a pseudoknot preceding the initiation codon that is characteristic of
a type IV IRES (Fig. S2A). Because type IV IRES elements typi-
cally occur in hepatitis C-related viruses and pestiviruses, this is
consistent with recombination events having occurred across viral
families, as described previously (16, 17). Irrespective of the type of
IRES, each of the genomes contains a series of predicted 5′ ter-
minal pseudoknots similar to those present in human HAV. No-
tably, each genome also contains a predicted cis-acting replication
element (cre) of variable size but conserved structure in the 3Dpol
region (18) (Fig. 2D and Fig. S2B).
Although these novel viruses were highly diversified (Fig. S2C),
they demonstrated only 32.4–47.4% distance in the translated
polyprotein sequence from human HAV, below the 58% thresh-
old separating Picornaviridae genera (6). Similarly, sequence dis-
tances in separate comparisons of the P1, P2, and P3 domains
were below commonly used thresholds, confirming that all of the
novel viruses belong to the genus Hepatovirus. Bayesian phylogenies
of the P1, P2, and P3 domains [typical picornavirus genomic
breakpoints (19)] demonstrated multiple topological incongru-
ences suggestive of past recombination events (Fig. 2E). These
topological incongruences are exemplified by the clustering of shrew
hepatovirus in a basal sister relationship to other hepatoviruses in
P1, but in an apical position together with rodent viruses in P3.
These results suggest genetic compatibility of diverse structural
and nonstructural elements from hepatoviruses infecting different
mammalian orders and emphasize the broad host tropism of
hepatoviruses suggested by ASR. Consistent with their phyloge-
netic clustering with human HAV, hepatoviruses from cricetid
rodents are predicted to contain the most closely related IRES and
cre elements, as well as 3A transmembrane domains (Fig. S2D).
Conservation of Unique Hepatovirus Features. Features common
to each of the nonprimate viruses and characteristic of hepatoviruses
include the predicted absence of a leader protein, a small VP4
(16-26 amino acids) lacking an N-terminal myristoylation signal,
an approximate 3- to 9-kDa C-terminal pX extension on VP1,
and the absence of a 2A protein. Thermodynamic modeling of
the VP2 structure suggests it is closely related to that of HAV,
which contains a unique domain swap found in insect Dicistroviridae
but not in mammalian picornaviruses (8) (Fig. 2F and Fig. S3 A
and B). YPX3L “late domain” motifs in VP2 (7) that contribute
to HAV membrane envelopment by mediating capsid interactions
with components of the endosomal sorting complex required
for transport (ESCRT) are highly conserved among nonprimate
hepatoviruses (Fig. 2G).
Further comparisons of the polyprotein sequences of these
novel hepatoviruses revealed several conserved domains in VP2
and VP3, suggesting the possibility of antigenic relatedness,
whereas there was extreme variation across the pX-2B genomic
region (Fig. 2H). Protein BLAST comparisons of these highly
divergent genomic regions revealed similarities with diverse
nonviral elements distantly related to various microbial organ-
isms (Fig. S3C). Thus, the hepatovirus pX-2B domain may be a
genomic hotspot potentially associated with host adaptation and
prone to acquisition of exogenous sequence elements. These
hypotheses are consistent with experimental data showing that
2B harbors key mutations associated with cell culture adaptation
of human HAV and that the pX domain tolerates large deletions
and exogenous sequence insertions (20, 21).
To determine whether the conserved antigenicity evident
among primate HAVs extends to the nonprimate viruses, we
sought evidence for antibodies recognizing human HAV in sera
from 111 bats (10 different species), 114 rodents (7 species, in-
cluding several samples PCR-positive for the most closely related
hepatovirus lineage), 103 shrews (3 species), and 48 hedgehogs
Fig. 2. Properties of the genomes of nonprimate hepatoviruses. (A) Hepatovirus
genome organization. SrHAV, shrew hepatovirus. (B) Genomic features in pri-
mate HAV, nonprimate HAV, and the Picornaviridae. [Scale bars, mean (SD).]
(C) IRES folding. RHAV, rodent hepatovirus; BtHAV, bat hepatovirus. (D) 3Dpol
cre elements. Gray, conserved AAACGmotif. Genomic positions of predicted cre:
HAV, 5,945–6,055; RHAV KS11-1230, 5,968–6,078; SrHAV KS12-1289, 6,095–6,181;
BtHAV, 5,809–5,870. (E) Phylogenies of hepatovirus domains P1, P2 (only 2C) and
P3 (only 3CD; MrBayes, WAG aa substitution model). Circles at nodes, posterior
probabilities >0.9. (F) VP2 structure of a SrHAV modeled onto the HAV crystal
(8); Box, domain swap. (G) VP2 late domains. (H) aa sequence distance along
hepatovirus polyproteins.
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(Table S2). Sera from bats, but no other animals, were reactive in
immunofluorescence assays (IFAs) of HAV-infected cells at
1:40–1:400 endpoint dilutions, with fluorescence patterns that
closely resembled those of a monoclonal antibody control serum
(Fig. 3A). Of eight positive sera (7.3%), six were from West Af-
rican Eidolon helvum, and one each from Central African Rou-
settus aegyptiacus and Micropteropus pusillus. To confirm these
results, we assessed the ability of Eidolon sera to immunoprecip-
itate (IP) human HAV. Four of the six IFA-positive sera that were
available in sufficient volumes were strongly reactive in this
assay, some exceeding the precipitating activity of anti-HAV
reference sera (Fig. 3B). These four sera also effectively neutral-
ized human HAV infectivity (Table S3). These results hint at
significant conservation of capsid antigenicity between the Eidolon
hepatovirus lineage and human HAV and are consistent with
conservation of the sequences of several neutralization epitopes
located in the capsid proteins VP3, VP2, and VP1 (Fig. 3C and
Fig. S4 A and B). An alternative explanation for the presence of
such antibodies in African bats could be exposure to human
HAV, perhaps by ingestion of contaminated surface water in
highly endemic areas (22). The unique ecologic traits of bats in-
cluding their longevity and spatial mobility compared with other
small mammals may facilitate repeated encounters with human
HAV in endemic areas. However, it seems unlikely that such an
exposure would be of sufficient magnitude to evoke antibody
responses without replication of the virus.
Because of the genetic relatedness between rodent hepatoviruses
and human HAV, the absence of cross-reactive antibodies in
rodent sera was surprising. It may be possible that rodents differ
from other small mammal hosts in the magnitude and onset
of their antibody response after hepatovirus infection, which
would be consistent with lack of antibodies in guinea pigs up to
60 d after experimental infection with HAV (9). Alternative ex-
planations may include subtle differences in complex epitopes located
in the hepatovirus antigenic sites. Resurrection or isolation of
rodent viruses for infection studies and development of hepatovirus-
specific serologic assays will aid comparative investigations in
further studies.
Pathogenesis and Ecology of Nonprimate Hepatoviruses.Hepatovirus
infection patterns in bats, rodents, hedgehogs, and shrews were
similar to those of HAV in primates. Viral RNA abundance
was highest in liver vs. other solid organs and blood in rodents,
shrews, and hedgehogs. In bats, liver, and several extrahepatic
tissues, including predominantly spleen, lung, and intestine,
showed high viral RNA concentrations (Fig. 4A). Viral RNA
was identified by in situ hybridization in bat hepatocytes and in
large mononuclear cells within the germinal center of splenic
lymphatic nodules (Fig. 4B). Comparable data are not available
for primate hepatoviruses, although HAV antigen has been
identified in splenic macrophages (23). Minus-strand RNA (a
replicative intermediate) was detected in the liver and spleen of
bats, but only in the liver of hedgehogs (Fig. S4C). We conclude
that these novel viruses are hepatotropic, but may also replicate
within the spleen in bats. Liver tissues from 23 PCR-positive and
49 PCR-negative bats, rodents, shrews, and hedgehogs were ex-
amined histologically. In some PCR-positive animals we observed
a mild increase in periportal inflammatory mononuclear cell in-
filtrates, but there was no consistent difference with control, PCR-
negative animals, and no severe liver pathology.
We next assessed infection outcome in 24 hedgehogs that were
serially monitored over a 220-d period in a German animal
shelter. Nine of these animals tested positive for hepatoviruses in
up to three separate specimens. The viruses identified in these
animals were 100% identical in their respective VP2 sequences,
consistent with the very low nucleotide substitution rate of hu-
man HAV (10) (Fig. S4D). Continuous fecal shedding of virus
(∼106 RNA copies per gram feces) was observed over 79–142 d
in four animals, resembling HAV shedding in humans (24)
(Fig. 4C). Importantly, in consecutive specimens taken less than
15 d apart, the second specimen consistently showed a significant
decrease in virus concentration, suggesting resolving acute in-
fections (Fig. 4C). Four animals completely cleared the infection
during the study period. When released, all nine infected hedgehogs
were in good physical condition, corroborating low hepatovirus
pathogenicity in these small mammals.
Finally, to gain insight into the epizootic nature of nonprimate
hepatoviruses, we analyzed specimens obtained over a 3-y period
in a German bat maternity roost within which females annually
form a colony lasting for approximately 3 mo, giving birth to
offspring in a synchronized fashion (25). Bat hepatovirus was
detected in fecal droppings immediately on colony formation in
early May 2008 (Fig. 4D and clade IV in Fig. 1B). The detection
rate decreased significantly 1 mo later, only to rise again after
parturition in mid-July. Shortly before bats left the colony toward
the end of that month, the detection rate fell for the second time.
These data suggest an absence of persistent infections in the
majority of animals, followed by a new wave of acute infections
in offspring, and resemble HAV outbreaks in children’s camps in
the prevaccine era (26). Resampling of the same maternity roost
(containing largely the same individuals) 2 y later failed to identify
Fig. 3. Antigenic relatedness of human and nonprimate hepatoviruses.
(A) (Upper) immunofluorescence assay (IFA) showing a bat serum reacting
with human HAV-infected FRhK-4 cells [red (Cy2); mixed with 50% non-
infected cells as internal negative controls]. (Lower) Same cells stained with a
monoclonal antibody control (mAb 7E7, 100% infected cells). Blue (DAPI),
nuclei. (B) Immunoprecipitation (IP) of HAV by bat sera [IF, IP, neutralization
test (NT); red, positive in all assays; gray, discordant assay results; empty,
negative in all assays], human sera, and controls. See SI Materials and
Methods for details on control sera. Dotted line, threshold precipitation
separating positive and negative control sera. (C) aa sequence distance be-
tween HAV (genotype Ia, GenBank accession no. AB020564), the Eidolon
BtHAV M32, a RHAV (RMU10-1637), and a SrHAV (KS12-1232).
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the same hepatovirus lineage, suggesting its extinction in this pop-
ulation. Instead, a highly divergent hepatovirus which was geneti-
cally related to viruses from shrews (clade I in Fig. 1B) was
identified in six specimens (Fig. S4E), illustrating that diverse hep-
atoviruses can be carried by a single host species. The level of amino
acid sequence divergence between the two hepatovirus lineages
infecting the roost in 2008 and 2010 exceeded 30% in the partial
VP2 domain (Fig. S4E), which is beyond the distance separating
enterovirus serotypes in this genomic region (27), thus hinting at the
existence of divergent serotypes in the genus Hepatovirus.
Discussion
We identified multiple, highly diversified hepatoviruses in nu-
merous small mammal taxa, extending the host associations of
the genus Hepatovirus well beyond primates. Our findings render
this picornavirus genus exceptionally speciose, comparable only
to the genus Enterovirus of the family Picornaviridae after de-
cades of investigation (6).
The unique properties of human HAV that are shared by these
novel nonprimate hepatoviruses and that distinguish it from other
mammalian picornaviruses likely reflect those of ancestral viruses
infecting small mammals before formation of the primate hep-
atovirus lineage. Whether the putative hepatovirus introduction took
place in the primate stem lineage preceding the split of Hominoidea
and Cercopithecoidea about 25 Mya (28) remains unknown because
of the scarcity of HAV strains recovered from nonhuman primates.
The survival of hepatoviruses before their introduction into primates
was likely mediated by large population sizes and/or high population
turnover of small mammal hosts (1, 3, 5). On the virus side, an
unusually broad host range and genetic plasticity is likely to have
contributed further to hepatovirus maintenance and evolution.
The existence of evolutionarily ancestral hepatoviruses in bats
and shrews compared with the presence of more closely related
viruses in rodents and primates is reminiscent of hantavirus host
associations, in which pathogenic human viruses originate from
rodents, whereas ancestral viruses occur in bats and Eulipotyphla
(29). The relevance of these Laurasiatherian hosts for the evo-
lutionary origins of human hepatitis viruses is demonstrated by
the recent detections of ancestral hepatitis B, C, and E viruses in
bats (30–32). It remains to be determined whether Laurasiatheria
generally harbor a wider genetic diversity of viruses than Euarch-
ontoglires and whether ecological traits such as insectivorous diets
influence viral diversity. However, reconstructions that point to a
Laurasiatherian host and an insectivorous diet for ancestral hep-
atoviruses provide a novel link to the structural phylogeny of the
HAV capsid and its close relationship to picorna-like viruses of
insects (8) and together suggest more distant ancestry in a pri-
mordial insect-borne virus. Such a scenario is paralleled by recent
suggestions of similar ancestry for other mammalian viruses (33–
35) and provides a new perspective on the origins of this ancient
human pathogen.
A major barrier to viral host switches is receptor use (36). Human
HAV uses the T-cell Ig and mucin domain 1 (TIM-1) for cell entry
(37). It will be important to investigate whether receptor use is
conserved among the nonprimate hepatoviruses we identified and to
determine whether these viruses are capable of infecting primate
hosts. Of note, human TIM-1 is used by other zoonotic viruses for
cell entry, including the bat-borne Ebola virus, the arthropod-borne
dengue virus and several rodent- and bat-borne New World arena-
viruses (38–40), illustrating that dependency on this molecule for cell
entry may not represent an insuperable barrier to a viral host switch.
Zoonotic infections with emerging viruses have become in-
creasingly relevant for human health due to the invasion of pristine
habitats by humans and their livestock, advancing global mobility,
and the rapid spread of pathogens within dense human populations
(41–43). The antigenic conservation we observed between HAV
and nonprimate hepatoviruses from Eidolon bats suggests these
viruses belong to a common serotype and that the introduction of
such viruses into human populations would be limited by herd
immunity and vaccine-induced immune responses. However, this
may not apply to all of the novel hepatovirus species we identified,
some of which on the basis of diversity within the P1 domain likely
comprise distinct serotypes. Our study exemplifies the utility of
looking beyond phylogenetic criteria alone when conducting risk
assessment for emerging RNA viruses and the need to include
functional, ecologic, and pathogenic analyses of animal reservoirs.
Materials and Methods
Sampling was done as described previously (3). Hepatovirus detection,
quantification, and genomic characterizations were done by PCR-based
techniques (see oligonucleotide sequences in Tables S4 and S5). Serologic
and histopathologic analyses were done as described previously (17). Details
of these and evolutionary analyses are given in SI Materials and Methods.
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animal M32), spleen (Upper Right, 400×, animal GH297), lung (Lower Left,
200×, animal M32), and intestine (Lower Right, 200×, animal M32). (C) Hep-
atovirus detections and RNA concentrations determined by qPCR in nine
hedgehogs sampled longitudinally. (D) Hepatovirus amplification in a bat ma-
ternity roost. Triangles, viral RNA concentrations in pooled fecal specimens over
five sampling points. Secondary y axis and orange line, detection rate.
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SI Materials and Methods
Sampling. All animals were handled according to national and
European legislation, namely the EU Council directive 86/609/
EEC for the protection of animals. For all sampling sites, study
protocols including capture, sampling, and testing of animals were
approved by the responsible animal ethics committees. All efforts
weremade tominimize suffering of animals. Any surgical procedure
was performed under sodium pentobarbital/ketamine anesthesia.
Trapping of rodents and shrews in Germany was conducted in the
framework of hantavirus monitoring activities coordinated by the
Friedrich-Loeffler-Institute, the Federal Research Institute for
Animal Health, as described previously (17); trapping of rodents in
other European, African, and Asian countries was described pre-
viously (17). Sampling of hedgehogs was done in a German shelter
as described previously (44). Sampling of bats was done using mist
nets or harp traps as described previously (3). Longitudinal sampling
in a bat maternity roost was done as described previously (25).
RNA Purification. Viral RNA was purified from ∼30 mg of tissue
from solid organs using the RNEasy Kit (Qiagen) as described
previously (3) or the MagNA Pure 96 DNA and Viral NA Small
Volume Kit (Roche) from blood (input volumes varying between
10 and 50 μL depending on the available volume) or 50 mg feces
suspended in an RNAlater (Qiagen) solution as described pre-
viously (17).
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Hepatovirus Detection, Quantification, and Genomic Characterization.
Hepatovirus RNA was detected in a hemi-nested RT-PCR with
primers designedunder consideration of all divergentHAVsequences
available in GenBank and the genetically related tremovirus Avian
encephalomyelitis virus (AEV). Oligonucleotide primer sequences
were HAV-F1089, GAGATAYCAYACWTATGCIAGATTTGG;
HAV-R1481, CTRAATTCRTTICTCATCATYTGTG; HAV-
R1544, GACATYTTIGCYCTIGCATCYTC. Screening fragments
were extended toward the 3′ ends by using consensus reverse
oligonucleotides designed to work for all hepatoviruses (HAV-
R2009, ACYCTRTANGGTGTRTCWSANATCCANGG; HAV-
R4415, CCATANANRTARCANACAACWGGYTCA) in a
cDNA synthesis using the SuperScript III reverse transcriptase (Life
Technologies) at 45 °C during 1 h (Y = C/T, W = A/T, I = inosine,
R = G/A, S = G/C, N = A/C/T/G), with inner gene-specific oligo-
nucleotide forward primers designed after Sanger sequencing of the
screening PCR amplicon. The final VP2 dataset used for all phy-
logenetic analyses comprised 864 nucleotides corresponding to ge-
nomic positions 1,123–1,986 in the HAV prototype strain HM175/
p16 (GenBank accession no. KP879217). The screening PCR first
round used the SuperScript III OneStep RT-PCR kit (Life Tech-
nologies) in a 25-μL reaction volume, with 600 nmol of respective
forward and reverse primers, 800 μmol of MgSO4, 1× reaction
buffer, 1 μg of PCR-grade BSA, 1 μL enzyme mix, and 5 μL RNA
extract. The thermal cycling profile involved 20 min at 50 °C for
reverse transcription, followed by 3 min at 95 °C, 10 cycles of 15 s at
94 °C, 15 s at 60 °C (with a decrease of 0.5 °C per cycle), and 40 s
at 72 °C; another 40 cycles of 15 s at 95 °C, 15 s at 54 °C, and 40 s at
72 °C, with a final elongation step of 2 min at 72 °C. The second
round used 1 μL first-round PCR product, 1× Platinum Taq Buffer
(Life Technologies), 200 nmol of deoxynucleotide triphosphates
each, 2.5 mmol of MgCl2, and 1 U of Platinum Taq polymerase in a
total volume of 50 μL. The amplification protocol was as in the first
round, without the RT step. PCR fragments were visualized by
agarose gel electrophoreses with ethidium bromide staining.
Quantification was done using strain-specific real-time RT-PCR
assays, using photometrically quantified cRNA controls as stan-
dards in vitro transcribed from TA-cloned PCR amplicons con-
taining the respective target regions. Table S4 shows real-time RT-
PCR oligonucleotide sequences. Genomic characterizations were
done by amplifying genomic sequence islets using broadly reactive
PCR primers designed as above, Sanger sequencing of amplicons
and amplification of genomic regions between islets using gene-
specific bridging forward and reverse primers, followed by primer
walking to sequence large PCR amplicons, generated using the
Expand High Fidelity kit (Roche). Broadly reactive primers for
genomic islet amplification are shown in Table S5. Genome ends
were characterized using a rapid amplification of cDNA ends
(RACE) strategy using the 5′/3′ RACE Kit (Roche). Strand-specific
cDNA priming was done using the SSIII RT (Life Technologies)
with a manual hotstart using two separate mixes: one containing
enzyme, buffer, primers, and water, and another containing RNA,
water, and buffer in a preheated thermocycler for 20 min at 60 °C.
After denaturation of the reverse transcriptase at 80 °C for 20 min,
cDNA was amplified using the strain-specific real time PCR assays
detailed in Table S4. To control for unspecific priming or self-
priming, cDNA synthesis was done in parallel without primers. To
avoid false-negative results from RNA degradation after repeated
freeze-thawing cycles of primary nucleic acid eluates, RNA was
newly purified from four bats and four hedgehogs of which suffi-
cient clinical specimens were still available. No adequate material
was available from rodents and shrews.
Host Typing. In cases of detection of closely related hepatoviruses in
distinct hosts, morphological hosts designations done by specialized
field biologists were confirmed by amplification and sequencing of
the partial mitochondrial COI gene modified from ref. 45. Mor-
phological and molecular typing was consistent in all hosts.
Bioinformatics. Phylogenies were done with MrBayes V3.1 (46)
using a WAG amino acid or a GTR+G+I nucleotide substitution
matrix. Two million MCMC iterations were sampled every 100
steps, resulting in 20,000 trees. Burn-in was generally 25% of tree
replicates. AEV was generally used as an outgroup. Visualization
and annotation was done with FigTree V1.4 from the BEAST
package. Myristoylation sites were predicted with the MYR pre-
dictor (47). Protein modeling was done using the SWISS-MODEL
web server and visualized using the UCSF Chimera package.
Comparisons of predicted protein secondary structures across
sequence alignments were done using ESPript V3.0 (48). IRESes
were folded manually and using mfold (49). Prediction of cre-
elements was done using mfold (49) in agreement with ref. 18. G+C
content, CpG bias, and codon usage were determined using SSE
V1.2 (50). Sequence distances within and between hepatovirus
polyproteins were calculated using SSE V1.2 (50) with a 250-aa
sliding window and a 25-aa step. Picornaviridae genera used for
comparisons included Aphthovirus, Aquamavirus, Avihepatovirus,
Avisivirus, Cardiovirus, Cosavirus, Dicipivirus, Enterovirus, Erbovirus,
Gallivirus, Hunnivirus, Kobuvirus, Kunsagivirus, Megrivirus, Mischivirus,
Mosavirus, Oscivirus, Parechovirus, Pasivirus, Passerivirus, Rosavirus,
Sakobuvirus, Salivirus, Sapelovirus, Senecavirus, Sicinivirus, Teschovirus,
and Tremovirus. Sequence distances and neighbor-joining phylogenetic
reconstructions were generated using MEGA5 (51). Transmembrane
domains were predicted using TMPRED from the Expasy portal
(52). ASRs were done in Mesquite as described previously (3). NT
sites were selected as summarized in ref. 8. Genome annotations
were done on MAFFT alignments and homology to the HAV 18f
reference sequence. Nonrecombinant HAV strains representing the
full viral diversity in humans were selected for phylogenetic re-
constructions. Virus concentrations in solid organs were plotted,
and χ2 tests for detection rates in the bat maternity roost with one-
tailed P values were calculated using SPSS V22 (IBM). The hep-
atovirus host tree was reconstructed using systematic constraints
(available upon request).
Serology. An indirect IFA was done using FRhK-4 cells persis-
tently infected with HAV. Cells were fixed with paraformaldehyde
[4% (vol/vol)], permeabilized with 0.5% Triton X-100 in 1×
PBS for 5 min, and processed as described previously (53). Bat
sera were diluted 1:50. Reactions were detected with goat-anti-
bat Ig (Bethyl; 1:1,000) and cyanine 2 (Cy2)–labeled donkey
anti-goat Ig (Dianova; 1:100). Rodent sera were tested at 1:10
or 1:40 dilution, depending on the available volumes. For sec-
ondary detection, a goat anti-mouse Ig (Dianova; 1:2,000) and
a donkey anti-goat cyanine 3-labeled Ig (Dianova; 1:200) were
used. Shrew and hedgehog sera were tested at a 1:10 dilution.
For secondary detection, a rabbit-anti-shrew Ig (1:200) and a
goat anti-rabbit cyanine 3-labeled Ig (Dianova; 1:200) were
used. Reactivity of the secondary anti-shrew Ig with hedgehog
Ig was confirmed previously (44). Infected cells (100% of cells
infected) were mixed with noninfected cells in 1:1 ratio to allow
internal negative controls. Additionally, mock-infected cell cultures
were used as controls with sera from each animal group under
study to exclude nonspecific reactivity with potential cell culture
contaminants.
IP was done as follows: 100 μL cell culture supernatant con-
taining the HAV/7 variant of the prototype strain HM175 with a
concentration of 3.8 × 109 RNA copies/mL was incubated with
30 μL human/bat serum in a 500-μL reaction containing 220 μL
incubation buffer and 150 μL of RNase-free water on a tumbler
overnight, followed by overnight incubation with prewashed
Dynabeads Protein G for Immunoprecipitation (Life Technol-
ogies), followed by five washing steps using a buffer containing
TritonX-100, DTT, and protease inhibitor (Roche), followed by
RNA purification using the TRIzol LS kit (Life Technologies)
and an RNeasy cleanup protocol (Qiagen) with an elution vol-
ume of 30 μL, of which 5 μL were tested by real-time RT-PCR as in
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ref. 54 with in vitro transcribed cRNA controls for quantification.
The HAV-specific TaqMan real time RT-PCR assay oligonucleo-
tide binding sites (54) had several nucleotide mismatches with the
Eidolon bat virus, making cross-detection highly unlikely. To further
exclude cross-detection of coprecipitated bat hepatovirus by the
HAV-specific real time RT-PCR assay, the bat-specific real time
RT-PCR used for quantification (Table S4) was performed on all
bat sera used for IP. Only one serum tested weakly positive. To
further rule out falsely high HAV-specific real-time RT-PCR re-
sults, a second real-time RT-PCR assay was designed specifically
for the HAV inoculum and contained >30 nucleotide mismatches
with the bat hepatovirus (Table S4 shows oligonucleotide se-
quences of the specific assay). All results were consistent with the
initial HAV-specific quantification. Negative human control sera
were determined using an IgM/IgG ELISA kit on an architect
platform (Abbott). Additional negative controls were mAbs against
the paramyxovirus SV5 (Abcam), the rhabdovirus Vesicular sto-
matitis virus (Sigma), the hepatitis C virus (HCV) E1 and E2 pro-
teins (Santa Cruz), and polyclonal rabbit sera raised against the
HCV NS3 (Abbiotec) and avian Influenzavirus A H5N1 (Abcam),
as well as a human polyclonal serum against the hepatitis B surface
antigen (0.2 IU/mL; NIBSC). Bat sera were additionally tested in
1:50 and 1:500 dilutions in PBS, yielding near-identical quantitative
relationships.
A virus neutralization test (NT) was performed as described in
ref. 55 with minor modifications. HAV [104 50% tissue culture
infective dose (TCID50)/mL; 1.5 × 10
5 RNA copies/mL as quan-
tified by real-time RT-PCR] was incubated with 50 μL of sera/mL
or 20 and 50 mU of monoclonal anti-HAV IgG antibody 7E7
(Mediagnost), respectively, as controls on a tumbler for 3 h at
room temperature in DMEM. Neutralization was assayed by in-
fection inhibition, which was determined by titration on FRhK-4
cells (TCID50 titer) and compared with that obtained with HAV
alone in amounts equal to those in the approaches with serum.
Serum samples, which reduced the HAV titer by at least one log
(more than 90% neutralization), were considered positive for anti-
HAV neutralizing antibodies. As additional controls, HAV
(104 TCID50/mL) was treated with human anti–HAV-positive
as well as -negative sera or 1–15 mU/mL of the WHO interna-
tional standard for anti-HAV Ig (NIBSC). TCID50 titer was de-
termined 12 d after inoculation by IFA using the 7E7 monoclonal
antibody (1:800; Mediagnost) with a goat anti-mouse Alexa488-
coupled secondary antibody (1:1,000; Life Technologies) and
calculated by the Kärber method.
In Situ Hybridization. RNAScope RNA probes targeting ∼1,000
nucleotides of the VP2 and VP3 genes of Eidolon helvum hep-
atoviruses were custom designed by Advanced Cell Diagnostics.
Specimens M32 and GH297 were selected due to best tissue
quality and high virus concentration in several organs. In situ
hybridization was performed as described by the manufacturer.
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Fig. S1. Host relationships, hepatovirus relationships, viral species prediction, and genomic properties. (A) Phylogenetic relationships of mammals included in
this study. Relationships of placental mammals according to ref. 56. Sampled taxa are colored. The superorder Afrotheria contains the sampled order Afro-
soricida. (B) Phylogenetic relationships of hepatoviruses in the partial VP2 encoding domain. Values at nodes show support of grouping from Bayesian pos-
terior probabilities. (C) VP2-based species prediction. Pairwise amino acid sequence distances in the translated VP2 were plotted for the complete dataset
shown in B. The 7% cutoff separating hepatovirus species in this dataset is highlighted by a slashed line. The distance to the next closely related genus
Tremovirus (represented by AEV) is highlighted to the right. (D) Hepatovirus genome architecture. Rodent hepatovirus (RHAV), bat hepatovirus (BtHAV),
Legend continued on following page
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hedgehog hepatovirus (HgHAV), and shrew hepatovirus (SrHAV). Near-identical HgHAV and SrHAV genomes were represented by one virus only. Genome
lengths are given to the right. Domains whose initiation and termination could not be unambiguously identified are shown with curved lines. Annotations and
additional genomic features correspond to those in the main article file. The 5′UTR of BtHAVs FO1A-F48 and M32 could not be completely characterized
despite repeated trials. The uncharacterized portion is given with a dotted line and the minimum genome size is identified with >. The HAV reference se-
quence corresponds to the 18f prototype strain. (E) Genomic features of hepatoviruses compared with other picornaviruses. (Top) Percentage G+C content of
hepatovirus genomes. (Middle) Relative CpG content of hepatoviruses compared with representative picornaviruses (FMDV, foot-and-mouth disease virus,
genus Aphthovirus; AiV, Aichi virus, genus Kobuvirus; SafV, Saffold virus, genus Cardiovirus; PV3, Polio virus 3, HRV89, human rhinovirus 89, both genus
Enterovirus; HPeV1, human parechovirus 1, genus Parechovirus; AEV, genus Tremovirus). (Bottom) Effective number of codons. In all panels, dashed lines show
minimum and maximum of primate HAV.
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Fig. S2. Hepatovirus secondary structures and diversity in different genome regions. (A) Predicted hepatovirus 5′UTR RNA secondary structure of viruses not
shown in the main text. Stem-loops (SL) are identified by adjacent numbers. Pseudoknots are given as boxes. Pictograms represent the full 5′UTR from the most
5′ nucleotide to the polyprotein initiation codon at the 3′-end. HgHAV Igel68 represents viruses Igel8 and Igel68; RHAV RMU10-1637 represents the near-
identical virus KS11-510 (all these structures were type III IRES-related; SMG-18520 represents Malagasy bat virus; CIV459 represents Ivorian rodent virus). Both
viruses contained type IV-like IRES structures including the characteristic pseudoknot preceding the initiation codon. Unpaired sequence between SL I and SL II
is represented by dots for graphical reasons. (B) Predicted hepatovirus cis-acting replication elements (cre) in the 3Dpol genomic region. Hosts are shown with
pictograms together with virus strains, HAV is included as a reference (genotype Ia, GenBank accession no. AB020564). The conserved AAACG motif in the
upper loop structure is highlighted. Rodent virus RMU10-1637 is represented by the near-identical virus KS11-510. Shrew virus KS12-1289 represents the near-
identical virus KS12-1232. Hedgehog virus Igel8 represents the near-identical viruses Igel68 and Igel75. (C) Pairwise amino acid sequence distances in the
translated VP1, P1, the combined 2C+3CD domains, and the full polyprotein gene plotted for the dataset containing all full genomes used to generate
phylogenetic reconstructions shown in the main article. Distances within HAV and those to the next closely related AEV are highlighted. (D) Predicted
transmembrane domains of hepatoviruses.
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Fig. S3. Conservation of hepatovirus VP2 proteins and divergence of hepatovirus 2B proteins. (A) Bayesian phylogeny of the full VP2 using a WAG amino acid
substitution model as detailed in SI Materials and Methods. Filled circles at nodes represent Bayesian probabilities above O.9. (B) Identification of structural
elements [α-helices, 310-helices (η), β-strands, and strict β-turns (TT)] using the structural models built on the HAV crystal structure (8). Conserved alignment
domains are highlighted by red color and boxes. The dot symbol at the C terminus of RHAV CIV459 corresponds to a gap compared with the other sequences.
(C) Protein BLAST comparisons of pX and 2B domains. In comparisons of HAV; hepatoviruses were excluded as hits. For each genome segment, the number of
residues with identical or biochemically similar residues is indicated per the total number of compared residues. The BLOSUM62 matrix was used for similarity
calculations by BLAST according to default parameters.
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Fig. S4. Hepatovirus epitopes and infection patterns. (A) Amino acid sequence distance along the polyproteins between HAV (Gt Ia) and the nonprimate
hepatoviruses. A genomic representation of HAV is given on top. Near-identical viruses from rodents, hedgehogs and shrews are represented by one virus only.
(B) Hepatovirus epitopes associated with neutralization according to ref. 8. Background shading and residue color indicate biochemical properties of residues.
AEV was included for comparison. (C) Strand-specific cDNA priming in bat and hedgehog liver and spleen. The number of analyzed animals and biological
replicates is indicated on top and above organs, respectively. (D) Partial VP2 neighbor-joining percentage distance phylogeny of the hedgehog viruses in the
animal shelter (complete deletion option, 405 nucleotides, GenBank accession nos. KT452748–KT452765). Individual animals are color-coded, sampling number
corresponds to increasing time points. The three hedgehog viruses for which the full genomes were characterized were included for orientation. (E) (Upper
Left) Geographic location of the roost in Western Germany as detailed in ref. 25 and a picture of femaleMyotis myotis bats hanging from the roof of the attic
forming the roost. (Lower Left) Neighbor-joining amino acid percentage distance phylogeny highlighting the distance between the two hepatovirus lineages
detected in the roost in 2008 and 2010 compared with the maximum distance in HAV using the same VP2 fragment. (Right) Detections of lineage 1 during 2008
and detections of lineage 2 during 2010. Height of bars correspond to viral RNA copies per gram of feces; empty spaces correspond to negative samples. The
arrow symbolizes the birth of the first pup, after which all pups are born in a short time frame. Height of bars in 2010 was set to 101 to highlight that these
specimens were detectable only by nested RT-PCR but could not be quantified using a strain-specific real-time RT-PCR assay due to low RNA concentrations.
Data for the year 2009 is not shown because this sample was incomplete as detailed in ref. 25 and no specimen tested positive for hepatoviruses.
Other Supporting Information Files
Table S1 (DOCX)
Table S2 (DOCX)
Table S3 (DOCX)
Table S4 (DOCX)
Table S5 (DOCX)
Drexler et al. www.pnas.org/cgi/content/short/1516992112 8 of 8
